SCHEMBL21717430

SCHEMBL21717430

c1ccc(-n2c3ccccc3c3ccc(-c4nc(-n5c6ccccc6c6cc7ccc(-n8c9ccccc9c9ccc%10ccccc%10c98)cc7cc65)c5ccccc5n4)cc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.35
ROCK2 O75116 2/20 0.34
ROCK1 Q13464 1/20 0.34
PKN1 Q16512 1/20 0.34
PKN2 Q16513 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
PRSS1 P07477 1/20 0.34
CYP1A2 P05177 4/20 0.33
CYP3A4 P08684 4/20 0.33
CYP2D6 P10635 4/20 0.33
TP53 P04637 2/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
GBA1 P04062 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716567 0.94 ABCG2 (0.39) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21717432 0.93 ROCK2 (0.35) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21717220 0.93 ABCG2 (0.39) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21716406 0.90 ROCK2 (0.37) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21212862 0.90 ROCK2 (0.39) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21717695 0.90 ABCG2 (0.34) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21717397 0.90 ATM (0.34) ROCK2ROCK1PKN1PKN2KDM4E
SCHEMBL21716407 0.90 ROCK2 (0.35) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21212861 0.89 KDM4E (0.43) ABCG2ROCK2ROCK1PKN1PKN2
SCHEMBL21716400 0.89 ABCG2 (0.38) ABCG2ROCK2ROCK1PKN1PKN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 ABCG2 2584/4885ROCK2 3979/4885ROCK1 2759/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 ABCG2 2584/4885ROCK2 3979/4885ROCK1 2759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.